Literature DB >> 11568918

Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect.

L I Al-Gazali1, R Padmanabhan, S Melnyk, P Yi, I P Pogribny, M Pogribna, M Bakir, Z A Hamid, Y Abdulrazzaq, A Dawodu, S J James.   

Abstract

The association of neural tube defects (NTDs) with Down syndrome (trisomy 21) and altered folate metabolism in both mother and affected offspring provide a unique opportunity for insight into the etiologic role of folate deficiency in these congenital anomalies. We describe here the case of a male child with trisomy 21, cervical meningomyelocele, agenesis of corpus callosum, hydrocephaly, cerebellar herniation into the foramen magnum, and shallow posterior cranial fossa. Molecular analysis of the methylenetetrahydrofolate (MTHFR) gene revealed homozygosity for the mutant 677C-->T polymorphism in both the mother and child. The plasma homocysteine of the mother was highly elevated at 25.0 micromol/L and was associated with a low methionine level of 22.1 micromol/L. Her S-adenosylhomocysteine (SAH) level was three times that of reference normal women, resulting in a markedly reduced ratio of S-adenosylmethionine (SAM) to SAH and significant DNA hypomethylation in lymphocytes. The child had low plasma levels of both homocysteine and methionine and a reduced SAM/SAH ratio that was also associated with lymphocyte DNA hypomethylation. In addition, the child had a five-fold increase in cystathionine level relative to normal children, consistent with over-expression of the cystathionine beta synthase gene present on chromosome 21. We suggest that altered folate status plus homozygous mutation in the MTHFR gene in the mother could promote chromosomal instability and meiotic non-disjunction resulting in trisomy 21. Altered folate status and homozygous TT mutation in the MTHFR gene in both mother and child would be expected to increase the risk of neural tube defects. The presence of both trisomy 21 and postclosure NTD in the same child supports the need for an extended periconceptional period of maternal folate supplementation to achieve greater preventive effects for both NTD and trisomy 21. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568918     DOI: 10.1002/ajmg.1509

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  13 in total

1.  Is there a familial link between Down's syndrome and neural tube defects? Population and familial survey.

Authors:  Márcia R Amorim; Eduardo E Castilla; Iêda M Orioli
Journal:  BMJ       Date:  2003-12-08

2.  Does global hypomethylation contribute to susceptibility to neural tube defects?

Authors:  Richard H Finnell; Henk J Blom; Gary M Shaw
Journal:  Am J Clin Nutr       Date:  2010-04-07       Impact factor: 7.045

3.  The relationship between intracellular and plasma levels of folate and metabolites in the methionine cycle: a model.

Authors:  Tanya M Duncan; Michael C Reed; H Frederik Nijhout
Journal:  Mol Nutr Food Res       Date:  2012-11-12       Impact factor: 5.914

4.  MTHFR 677 TT genotype in a mother and her child with Down syndrome, atrioventricular canal and exstrophy of the bladder: implications of a mutual genetic risk factor?

Authors:  Heiko Reutter; Regina C Betz; Michael Ludwig; Thomas M Boemers
Journal:  Eur J Pediatr       Date:  2006-04-07       Impact factor: 3.183

5.  Construction of cDNA representational difference analysis based on two cDNA libraries and identification of garlic inducible expression genes in human gastric cancer cells.

Authors:  Yong Li; Lin Yang; Jian-Tao Cui; Wen-Mei Li; Rui-Fang Guo; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

6.  Methylmalonic acid in amniotic fluid and maternal urine as a marker for neural tube defects.

Authors:  Xiaoping Luo; Lian Zhang; Hong Wei; Wanjun Liu; Muti Wang; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

7.  A functional variant in the cystathionine β-synthase gene promoter significantly reduces congenital heart disease susceptibility in a Han Chinese population.

Authors:  Jian-Yuan Zhao; Xue-Yan Yang; Kai-Hu Shi; Shu-Na Sun; Jia Hou; Zhi-Zhou Ye; Jue Wang; Wen-Yuan Duan; Bin Qiao; Yi-Jiang Chen; Hong-Bing Shen; Guo-Ying Huang; Li Jin; Hong-Yan Wang
Journal:  Cell Res       Date:  2012-09-18       Impact factor: 25.617

Review 8.  Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.

Authors:  Henk J Blom; Yvo Smulders
Journal:  J Inherit Metab Dis       Date:  2010-09-04       Impact factor: 4.982

Review 9.  Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.

Authors:  Dominik Szwajgier; Ewa Baranowska-Wójcik; Joanna Grzelczyk; Wioletta Żukiewicz-Sobczak
Journal:  Dis Markers       Date:  2021-06-28       Impact factor: 3.434

10.  Leber hereditary optic neuropathy: do folate pathway gene alterations influence the expression of mitochondrial DNA mutation?

Authors:  A Aleyasin; M Ghazanfari; M Houshmand
Journal:  Iran J Public Health       Date:  2010-09-30       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.